• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Italy·Consumer Cyclical·VLS.MI
Share

Valsoia S.p.A. Stocks

€ 10.1Last Updated 22.07.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

€ 125.92M

€ 10.1
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Valsoia S.p.A. is an Italian firm engaged in the manufacturing, distribution, and sale of a broad spectrum of consumer food products, with a primary focus on health-oriented items. Its diverse product range includes plant-based alternatives (notably soy-based), beverages, ice creams, yogurts, desserts, biscuits, ready-to-eat meals, cheeses, condiments, fruit preserves and products, and tomato purees and sauces, alongside various dietary and nutritional supplements. The company markets these goods under a host of brands, including Valsoia Bontà E Salute, Santa Rosa, Valsoia Integratori, Pomodorissimo, Weetabix, Oreo, Vitasoya, Diete.Tic, Piadina Loriana, and Naturattiva. Founded in 1990, Valsoia S.p.A. maintains its headquarters in Bologna, Italy, and functions as a subsidiary of Finsalute S.r.l.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of VLS.MI is 13.5 and suggests 30.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.07.2026 20:56

U.S. indices extended their decline: The Nasdaq plunged 2.7%, and the fear index rose nearly 20%

23.07.2026 19:58

Wall Street is expecting a strong earnings report from Intel. Why it might not stop the stock's decline

23.07.2026 19:43

Oil production in Kazakhstan has plummeted following the shutdown of the main terminal — Reuters

23.07.2026 19:20

IBM has lowered its revenue growth forecast. How is the company trying to reassure investors?

23.07.2026 19:02

Nasdaq gets SEC OK for tighter rules on micro caps; almost 200 names face delisting

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026